NSE · SMSPHARMA
SMS Pharmaceuticals Limited (SMSPHARMA) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#864
of 5,047 stocks
▼ 211W▲ 471M
Peak #818 · 01 Nov 2026
SMS Pharmaceuticals Limited is a smallcap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 68%, is growing revenue at a solid clip, and commands a premium earnings multiple.
Market Cap
4,556.17 Cr
P/E Ratio
43.63
P/B Ratio
5.80
ROE
12.98%
ROCE
13.84%
Dividend Yield
0.08%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 316.09 Cr | 206.96 Cr | 237.95 Cr | 210.45 Cr |
| Net Profit | 39.85 Cr | 20.91 Cr | 32.71 Cr | 23.47 Cr |
| EPS | 4.26 | 2.23 | 3.58 | 2.59 |
| Operating Profit | 58.55 Cr | 32.70 Cr | 32.34 Cr | 37.38 Cr |
Shareholding pattern
Promoter
68.07%
Public
31.93%
PUBLIC BREAKDOWN
FII
0.65%
DII
2.83%
MF (within DII)
2.81%
Individuals
26.35%
Mutual fund holdings
₹0.06
Cr total
2
Schemes
2
Fund Houses
₹0.06 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.04 Cr (67.5%)
Bandhan Mutual Fund₹0.02 Cr (32.5%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 22 Sep 2026 | Dividend | Dividend - Re 0.40 Per Share |
| 22 Sep 2025 | Dividend | Dividend - Re 0.40 Per Share |
| 23 Sep 2024 | Other | Annual General Meeting |
| 23 Sep 2024 | Dividend | Dividend - Rs 0.40 Per Share |
| 22 Sep 2023 | Other | Annual General Meeting |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.